Skip to main content

The 'Batman' Killings: Trial Nears

 I know that a lot of news has passed under the current-events bridge of late, but: does everyone remember the Batman murders in Aurora, Colorado? Summer of 2012?
I recall it because the trial date in approaching (October '14) and because it has already spurred some ancillary appellate litigation in which regular readers of this blog may well have opinions.
 The US Supreme Court decided on May 27, 2014 that it would not hear an appeal from a decision of the highest state court in New York. That court had employed the state's "shield" law to quash a subpoena issued in Colorado. so you have issues of interstate comity, state/federal relations etc.
The gist of it is that somebody involved in this case violated a trial court gag order issued by the Colorado court and talked to a reporter in New York. [A reporter for Fox News, which of course doesn't matter as a matter of legal principle at all but may matter to some readers for all I know. Further, I suspect that if Jana Winters worked for, say, CBE or Reuters we'd be hearing a lot about this from Fox. In a tone of outrage. Anyway.... ]
The reporter, Jana Winters, the lass whose photo you see here, ran with a story about Holmes' contact with a University of Colorado psychologist based on her anonymous and gag-order-violating sources.
The defense counsel sought and obtained the subpoena that would require Winters to tell them who her sources were. Perhaps the defense counsel want cross-examination material against some potential prosecution witness who may also have been the leaker. I don't know.
The highest court in NY State agreed with Fox's lawyers that Winters is protected by that state's shield law and can ignore the subpoena. The US Supreme Court has allowed that decision to stand, by refusing to hear Holmes' appeal.   
See More


  1. Part or all of this post was stolen by the blogger at He did it to me too (and several others as well.) His blog needs to be taken down! As of today, I have been unable to contact him. Perhaps you will have better luck. Just thought you should know that someone is stealing from you.


Post a Comment

Popular posts from this blog

A Story About Coleridge

This is a quote from a memoir by Dorothy Wordsworth, reflecting on a trip she took with two famous poets, her brother, William Wordsworth, and their similarly gifted companion, Samuel Taylor Coleridge.

We sat upon a bench, placed for the sake of one of these views, whence we looked down upon the waterfall, and over the open country ... A lady and gentleman, more expeditious tourists than ourselves, came to the spot; they left us at the seat, and we found them again at another station above the Falls. Coleridge, who is always good-natured enough to enter into conversation with anybody whom he meets in his way, began to talk with the gentleman, who observed that it was a majestic waterfall. Coleridge was delighted with the accuracy of the epithet, particularly as he had been settling in his own mind the precise meaning of the words grand, majestic, sublime, etc., and had discussed the subject with William at some length the day before. “Yes, sir,” says Coleridge, “it is a majestic wate…

Cancer Breakthrough

Hopeful news in recent days about an old and dear desideratum: a cure for cancer. Or at least for a cancer, and a nasty one at that.

The news comes about because investors in GlaxoSmithKline are greedy for profits, and has already inspired a bit of deregulation to boot. 

The FDA has paved the road for a speedy review of a new BCMA drug for multiple myeloma, essentially cancer of the bone marrow. This means that the US govt has removed some of the hurdles that would otherwise (by decision of the same govt) face a company trying to proceed with these trials expeditiously. 

This has been done because the Phase I clinical trial results have been very promising. The report I've seen indicates that details of these results will be shared with the world on Dec. 11 at the annual meeting of the American Society of Hematology. 

The European Medicines Agency has also given priority treatment to the drug in question. 

GSK's website identifies the drug at issue as "GSK2857916," althou…

Hume's Cutlery

David Hume is renowned for two pieces of cutlery, the guillotine and the fork.

Hume's guillotine is the sharp cut he makes between "is" statements and "ought" statements, to make the point that the former never ground the latter.

His "fork" is the division between what later came to be called "analytic" and "synthetic" statements, with the ominous observation that any books containing statements that cannot be assigned to one or the other prong should be burnt.

Actually, I should acknowledge that there is some dispute as to how well or poorly the dichotomy Hume outlines really maps onto the analytic/synthetic dichotomy. Some writers maintain that Hume meant something quite different and has been hijacked. Personally, I've never seen the alleged difference however hard they've worked to point it out to me.

The guillotine makes for a more dramatic graphic than a mere fork, hence the bit of clip art above.

I'm curious whe…